Literature DB >> 22850208

Dipeptidyl peptidase-4 inhibitor with β-amino amide scaffold: synthesis, SAR and biological evaluation.

Heung Jae Kim1, Woo Young Kwak, Jong Pil Min, Si Young Sung, Ha Dong Kim, Mi Kyung Kim, Hae Sun Kim, Kyung Jin Park, Moon Ho Son, Soon Hoe Kim, Bong Jin Lee.   

Abstract

Inhibitors of dipeptidyl peptidase-4 (DPP4) have been shown to be effective treatments for type 2 diabetes. Several series of β-amino amide containing piperazine derivatives have been prepared and evaluated as a inhibitor of DPP4. Finally compound 5m was selected for further evaluation.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22850208     DOI: 10.1016/j.bmcl.2012.07.019

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  2 in total

1.  Comparative Study to Predict Dipeptidyl Peptidase IV Inhibitory Activity of β-Amino Amide Scaffold.

Authors:  S Patil; R Sharma; A Abhishek
Journal:  Indian J Pharm Sci       Date:  2015 Mar-Apr       Impact factor: 0.975

2.  Navigating the chemical space of dipeptidyl peptidase-4 inhibitors.

Authors:  Watshara Shoombuatong; Veda Prachayasittikul; Nuttapat Anuwongcharoen; Napat Songtawee; Teerawat Monnor; Supaluk Prachayasittikul; Virapong Prachayasittikul; Chanin Nantasenamat
Journal:  Drug Des Devel Ther       Date:  2015-08-10       Impact factor: 4.162

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.